Data / Research funding / Stomach Cancer
Stomach Cancer: 111 NIH awards ($153.3M) to 46 organizations
111 NIH awards ($153.3M) in the NIH spending category Stomach Cancer, to 46 organizations, read 2026-11-03. NIH fiscal years 2021 to 2025.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- Topic
- NIH spending category
Awards
111 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| The role of stem cells and the microenvironment in gastrointestinal cancers | NIH | National Cancer Institute | 2021 to 2025 | $5,569,272 | January 7, 2016 | August 31, 2030 | WANG, TIMOTHY CRAGIN | reporter.nih.gov |
| Cell plasticity in the origin of gastric carcinogenesis | NIH | National Cancer Institute | 2022 to 2025 | $5,262,457 | September 1, 2025 | August 31, 2027 | CHOI, EUNYOUNG | reporter.nih.gov |
| Center for Gastric Pre-Cancer Atlas of Multidimensional Evolution in 3D (GAME3D) | NIH | National Cancer Institute | 2024 to 2025 | $5,158,661 | September 1, 2024 | August 31, 2029 | WANG, LINGHUA | reporter.nih.gov |
| Mechanisms underlying gastric intestinal metaplasia and carcinogenesis | NIH | National Cancer Institute | 2022 to 2025 | $4,560,310 | September 20, 2022 | August 31, 2027 | RUSTGI, ANIL K | reporter.nih.gov |
| Initiation of Diffuse and Intestinal Non-Cardia Gastric Cancer | NIH | National Cancer Institute | 2022 to 2025 | $4,080,056 | September 1, 2025 | August 31, 2027 | RYEOM, SANDRA | reporter.nih.gov |
| Comparative modeling of gastric cancer health drivers and prevention in the US and globally | NIH | National Cancer Institute | 2021 to 2025 | $4,054,972 | September 15, 2021 | August 31, 2026 | HUR, CHIN | reporter.nih.gov |
| Type IV Protein Secretion in Helicobacter pylori | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,592,685 | February 18, 2016 | March 31, 2027 | COVER, TIMOTHY L | reporter.nih.gov |
| University of California and UT Southwestern D-PDTC | NIH | National Cancer Institute | 2023 to 2025 | $3,532,429 | August 1, 2023 | July 31, 2028 | CARVAJAL CARMONA, LUIS GUILLERMO | reporter.nih.gov |
| Improving radiolabeled imaging and targeting of HER2 positive EG cancers using lovastatin | NIH | National Cancer Institute | 2021 to 2025 | $3,432,890 | December 1, 2020 | November 30, 2026 | LEWIS, JASON S. | reporter.nih.gov |
| Coordinating Center for the Program on the Origins of Gastroesophageal Cancers | NIH | National Cancer Institute | 2022 to 2025 | $3,140,717 | September 6, 2022 | August 31, 2027 | HUR, CHIN | reporter.nih.gov |
| Serial immunotherapy combination to modulate the tumor environment in patients with metastatic gastroesophageal cancer | NIH | National Cancer Institute | 2021 to 2025 | $3,119,133 | January 1, 2021 | December 31, 2026 | YOON, HARRY H | reporter.nih.gov |
| Determining the role of germline CDH1 variants in gastric cancer outcome disparities in Hispanic/Latino patients | NIH | National Cancer Institute | 2022 to 2025 | $2,914,814 | July 1, 2022 | June 30, 2027 | WANG, SAM C. | reporter.nih.gov |
| Multi-cancer early detection using cell-free DNA methylome analysis | NIH | National Cancer Institute | 2023 to 2025 | $2,757,500 | September 19, 2023 | August 31, 2028 | ZHOU, XIANGHONG JASMINE | reporter.nih.gov |
| Common Stem Cell of Origin for Junctional and Gastric Adenocarcinoma | NIH | National Cancer Institute | 2022 to 2024 | $2,754,572 | September 15, 2022 | August 31, 2027 | MCKEON, FRANK D. | reporter.nih.gov |
| HORMAD-specific TGF-beta resistant memory T cells for treatment of patients with Gastro-esophageal Cancer | NIH | National Cancer Institute | 2023 to 2024 | $2,717,589 | September 19, 2023 | August 31, 2025 | YEE, CASSIAN | reporter.nih.gov |
| Delineating the underlying reasons for the racial disparity in gastric cancer incidence in the United States | NIH | National Cancer Institute | 2022 to 2025 | $2,602,977 | September 1, 2022 | August 31, 2027 | EPPLEIN, MEIRA | reporter.nih.gov |
| Induction and Evolution of Metaplasia in the Stomach | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,589,535 | May 1, 2014 | May 31, 2027 | GOLDENRING, JAMES RICHARD | reporter.nih.gov |
| H. Pylori Relationship to Digestive Diseases and Cancer | NIH | National Cancer Institute | 2021 to 2025 | $2,573,159 | September 30, 1997 | April 30, 2028 | PEEK, RICHARD M. | reporter.nih.gov |
| HER2-targeting transformable nanotherapeutic platform against HER2+ cancers | NIH | National Cancer Institute | 2021 to 2024 | $2,533,940 | February 11, 2020 | January 31, 2026 | LAM, KIT S | reporter.nih.gov |
| Tumor cell lineage diversity and composition in gastric cancer progression and therapy resistance | NIH | National Cancer Institute | 2022 to 2025 | $2,524,055 | July 15, 2022 | June 30, 2027 | WANG, LINGHUA | reporter.nih.gov |
| Theranostic for gastric cancer | NIH | National Cancer Institute | 2023 to 2025 | $2,346,556 | September 11, 2023 | August 31, 2027 | HUMBLET, VALERIE | reporter.nih.gov |
| Drivers of gastric pre-neoplasia | NIH | National Cancer Institute | 2021 to 2025 | $2,339,784 | August 1, 2025 | July 31, 2027 | CHOI, EUNYOUNG | reporter.nih.gov |
| HER2-mediated delivery of cytotoxic agents in solid tumors | NIH | National Cancer Institute | 2021 to 2024 | $2,298,246 | April 1, 2021 | March 31, 2025 | CHANDARLAPATY, SARAT | reporter.nih.gov |
| Molecular Functions of CDK1 in Gastric Tumorigenesis | NIH | National Cancer Institute | 2021 to 2025 | $2,274,554 | January 12, 2021 | December 31, 2026 | EL-RIFAI, WAEL | reporter.nih.gov |
| HORMAD-specific TGF-beta resistant memory T cells for treatment of patients with Gastro-esophageal Cancer | NIH | National Cancer Institute | 2025 | $2,270,520 | September 19, 2023 | August 31, 2028 | YEE, CASSIAN | reporter.nih.gov |
| Intercepting novel functions of AURKA in gastric tumorigenesis | NIH | National Cancer Institute | 2022 to 2025 | $2,190,467 | September 1, 2022 | August 31, 2027 | EL-RIFAI, WAEL | reporter.nih.gov |
| Characterizing cytotoxic therapy induced shifts in the cost-to-benefit ratio of high ploidy | NIH | National Cancer Institute | 2022 to 2025 | $2,095,115 | September 1, 2022 | August 31, 2027 | ANDOR, NOEMI | reporter.nih.gov |
| Rapid ex vivo biosensor cultures to assess dependencies in gastroesophageal cancer | NIH | National Cancer Institute | 2022 to 2024 | $2,059,739 | April 1, 2022 | March 31, 2025 | BOEHM, JESSE SAMUEL | reporter.nih.gov |
| Interactions Between the Microbiota and Helicobacter pylori in Gastric Carcinogenesis | NIH | National Cancer Institute | 2023 to 2025 | $2,027,538 | June 1, 2023 | May 31, 2028 | PEEK, RICHARD M. | reporter.nih.gov |
| Genetic requirements of Helicobacter pylori infection | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $1,992,451 | December 1, 2003 | January 31, 2027 | SALAMA, NINA | reporter.nih.gov |
| Gasdermin E and pyroptosis in cancer | NIH | National Cancer Institute | 2021 to 2024 | $1,970,899 | April 3, 2020 | March 31, 2025 | LIEBERMAN, JUDY | reporter.nih.gov |
| Mechanisms of induction of gastric injury by H. pylori | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $1,956,698 | May 15, 2021 | April 30, 2027 | MARCUS, ELIZABETH A. | reporter.nih.gov |
| Rapid and flexible precision oncology mouse models of epithelial malignancies epithelial malignancies | NIH | National Cancer Institute | 2021 to 2024 | $1,908,434 | January 1, 2020 | December 31, 2024 | LOWE, SCOTT W. | reporter.nih.gov |
| Reversing Drug Resistance in Tumors with Clickable Antibody Pairs | NIH | National Cancer Institute | 2023 to 2025 | $1,869,482 | January 1, 2023 | December 31, 2027 | RIBEIRO PEREIRA, PATRICIA MANUELA | reporter.nih.gov |
| Molecular Understanding and Targeting of Determinant Factors in Gastric Tumorigenesis | NIH | National Cancer Institute | 2021 to 2025 | $1,819,525 | April 1, 2021 | March 31, 2027 | ZUO, XIANGSHENG | reporter.nih.gov |
| Ferroptosis and Cancer Cell Signaling | NIH | National Cancer Institute | 2022 to 2025 | $1,791,770 | February 1, 2022 | January 31, 2027 | JIANG, XUEJUN | reporter.nih.gov |
| Acoustofluidic Separation (AFS), Purification and Raman Spectral Fingerprinting of Single EVs: From Cell of Origin to Target Cell and Biofluids | NIH | National Center for Advancing Translational Sciences | 2021 to 2022 | $1,770,441 | September 5, 2019 | July 31, 2024 | WONG, DAVID T | reporter.nih.gov |
| Molecular dissecting and targeting YAP1 mediated cancer stemness and immune suppression in advanced gastric adenocarcinoma | NIH | National Cancer Institute | 2023 to 2025 | $1,756,768 | September 1, 2023 | August 31, 2027 | SONG, SHUMEI | reporter.nih.gov |
| Mechanisms Governing Expansion of Embryonic Progenitor Cells (EPCs) inMetaplasia | NIH | National Cancer Institute | 2021 to 2024 | $1,740,651 | June 10, 2020 | May 31, 2025 | MILLS, JASON C | reporter.nih.gov |
| Computational imaging approaches to personalized gastric cancer treatment | NIH | National Cancer Institute | 2023 to 2025 | $1,700,826 | March 1, 2023 | February 29, 2028 | LI, RUIJIANG | reporter.nih.gov |
| Plastic States Associated with Cellular Stress and Malignancy: Insights for Prevention and Treatment of Lethal Metaplastic Cancers | NIH | National Cancer Institute | 2021 to 2022 | $1,667,061 | January 19, 2016 | December 31, 2023 | TLSTY, THEA D | reporter.nih.gov |
| The Role of RHOA in Diffuse Gastric Cancer | NIH | National Cancer Institute | 2021 to 2022 | $1,607,160 | June 8, 2018 | December 31, 2022 | WANG, TIMOTHY CRAGIN | reporter.nih.gov |
| Helicobacter Pylori and Gastrointestinal Biology | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $1,600,756 | August 1, 2001 | June 30, 2025 | PEEK, RICHARD M. | reporter.nih.gov |
| The Role of Inflammation in Regulating Gastric Metaplasia | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $1,591,263 | March 1, 2023 | December 31, 2026 | DIPAOLO, RICHARD J | reporter.nih.gov |
| The role of type 2 inflammation in the initiation and progression of metaplastic differentiation and neoplastic transformation of gastric epithelia | NIH | National Cancer Institute | 2021 to 2024 | $1,585,931 | June 1, 2020 | May 31, 2026 | CHEN, ZHIBIN | reporter.nih.gov |
| Circulating metabolites as novel risk biomarkers for gastric cancer: a large multi-center prospective investigation | NIH | National Cancer Institute | 2024 to 2025 | $1,477,476 | September 18, 2024 | August 31, 2029 | SHU, XIANG | reporter.nih.gov |
| Pharmacokinetic strategies to increase monoclonal antibody uptake, distribution, and efficacy for treatment of solid tumors | NIH | National Cancer Institute | 2021 to 2024 | $1,419,043 | June 1, 2020 | May 31, 2025 | BALTHASAR, JOSEPH P | reporter.nih.gov |
| Targeting FGFR Alterations in Gastroesophageal Cancer | NIH | National Cancer Institute | 2024 to 2025 | $1,396,846 | July 15, 2024 | June 30, 2029 | RYEOM, SANDRA | reporter.nih.gov |
| Regulation of gastric metaplasia, dysplasia and neoplasia by Bone Morphogenetic Protein signaling | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $1,376,907 | September 18, 2020 | June 30, 2025 | TODISCO, ANDREA | reporter.nih.gov |
| Using artificial intelligence to discover spatial, genomic, and pathologic biomarkers to guide and augment immune checkpoint inhibitor therapy for gastric cancer | NIH | National Cancer Institute | 2024 to 2025 | $1,343,150 | April 1, 2024 | March 31, 2029 | WANG, SAM C. | reporter.nih.gov |
| IMAGINE: Intestinal Metaplasia And Gastritis INtErception Study | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $1,327,084 | March 1, 2024 | January 31, 2028 | GARMAN, KATHERINE | reporter.nih.gov |
| Ultrabright Theranostic SERRS Nanoparticles for Gastrointestinal Endoscopy | NIH | National Cancer Institute | 2022 to 2023 | $1,275,697 | February 1, 2018 | May 31, 2025 | ROGALLA, STEPHAN | reporter.nih.gov |
| RPMS1 circular RNAs in EBV malignancies | NIH | National Cancer Institute | 2021 to 2023 | $1,083,260 | June 1, 2019 | May 31, 2024 | FLEMINGTON, ERIK K | reporter.nih.gov |
| Genetic studies of homologous recombination deficiency in hispanic gastric cancer | NIH | National Cancer Institute | 2021 to 2022 | $1,050,582 | June 8, 2018 | May 31, 2024 | CARVAJAL CARMONA, LUIS GUILLERMO | reporter.nih.gov |
| A vascularized microphysiological system (MPS) platform for modeling peritoneal carcinomatosis | NIH | National Cancer Institute | 2024 to 2025 | $1,022,846 | June 1, 2024 | May 31, 2026 | HUGHES, CHRISTOPHER C. W. | reporter.nih.gov |
| A novel, short isoform of the +TIP microtubule (MT) binding protein CLIP170 confers taxane resistance by obstructing the MT pore. | NIH | National Cancer Institute | 2021 to 2022 | $972,795 | April 19, 2018 | March 31, 2024 | GIANNAKAKOU, PARASKEVI | reporter.nih.gov |
| Common Stem Cell of Origin for Junctional and Gastric Adenocarcinoma | NIH | National Cancer Institute | 2025 | $949,184 | September 15, 2022 | August 31, 2027 | MCKEON, FRANK D. | reporter.nih.gov |
| Structure and function of Helicobacter pylori VacA | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $944,680 | May 1, 1996 | November 30, 2024 | COVER, TIMOTHY L | reporter.nih.gov |
| PRECISE - a PErsonalized Risk Score for gastrIc CancEr | NIH | National Cancer Institute | 2021 to 2025 | $941,230 | March 1, 2021 | February 28, 2026 | HUANG, ROBERT JEFFREY | reporter.nih.gov |
| A Targeted Approach to the Surveillance of Precursor Lesions for Gastric Cancer | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $838,080 | May 1, 2021 | March 31, 2026 | LASZKOWSKA, MONIKA | reporter.nih.gov |
| Mechanisms and biomarkers in aberrant paligenosis-induced stomach tumorigenesis | NIH | National Cancer Institute | 2021 to 2024 | $797,640 | May 1, 2020 | April 30, 2025 | MILLS, JASON C | reporter.nih.gov |
| New carcinogenic mechanisms of Helicobacter pylori infection | NIH | National Cancer Institute | 2021 to 2025 | $778,445 | August 1, 2010 | April 30, 2030 | ZAIKA, ALEXANDER I. | reporter.nih.gov |
| Functional characterization of novel oncogenic loci driving progression and immune response in gastrointestinal cancer | NIH | National Cancer Institute | 2023 to 2025 | $747,000 | September 1, 2021 | August 31, 2026 | LO, YUAN-HUNG | reporter.nih.gov |
| Antigen-specific radiosensitization | NIH | National Cancer Institute | 2025 | $736,168 | August 1, 2025 | July 31, 2030 | HIGGINSON, DANIEL | reporter.nih.gov |
| Neoglycosylation Epitopes in Metaplasia and Cancer | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $661,748 | April 1, 2022 | January 31, 2027 | BROWN, JEFFREY WADE | reporter.nih.gov |
| Establishing roles for the type I interferon/double-stranded RNA response and Helicobacter pylori-specific transcripts in the progression to metaplasia in gastric epithelium | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $628,803 | September 1, 2019 | January 31, 2025 | SAENZ, JOSE BERNARDO | reporter.nih.gov |
| Genetic requirements of Helicobacter pylori infection | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $605,148 | December 1, 2003 | March 31, 2022 | SALAMA, NINA | reporter.nih.gov |
| Rapid ex vivo biosensor cultures to assess dependencies in gastroesophageal cancer | NIH | National Cancer Institute | 2021 | $566,213 | April 1, 2020 | December 31, 2021 | BOEHM, JESSE SAMUEL | reporter.nih.gov |
| Assessing feasibility of gastric cancer screening in the US | NIH | National Cancer Institute | 2025 | $564,414 | April 1, 2025 | March 31, 2030 | KIM, MICHELLE KANG | reporter.nih.gov |
| The double-stranded RNA (dsRNA) response in gastric pre-neoplasia | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $547,413 | January 1, 2025 | December 31, 2029 | SAENZ, JOSE BERNARDO | reporter.nih.gov |
| Role of Protein Kinase A (PKA)-mediated mesenchymal-epithelial crosstalk in gastric preneoplasia | NIH | National Institute of General Medical Sciences | 2023 to 2025 | $533,600 | July 17, 2023 | April 30, 2027 | PURI, PAWAN | reporter.nih.gov |
| The Role of Inflammation in Regulating Gastritis and Gastric Carcinogenesis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 | $485,826 | August 1, 2016 | August 31, 2023 | DIPAOLO, RICHARD J | reporter.nih.gov |
| Understanding the biology of disparity-associated genomically stable gastric tumors | NIH | National Cancer Institute | 2024 to 2025 | $483,000 | September 18, 2024 | August 31, 2026 | CARVAJAL CARMONA, LUIS GUILLERMO | reporter.nih.gov |
| Gastrointestinal microbiota interactions modulating gastric cancer progression | NIH | National Cancer Institute | 2022 to 2023 | $443,177 | July 1, 2022 | June 30, 2024 | SALAMA, NINA | reporter.nih.gov |
| Discovery of H. pylori T cell epitopes unique to minority populations that could contribute to increased gastric cancer rates. | NIH | National Cancer Institute | 2021 | $438,168 | May 1, 2021 | April 30, 2024 | SETTLES, ERIK W | reporter.nih.gov |
| Epstein-Barr Virus Entry into Epithelial Cells | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $429,534 | June 3, 2024 | April 30, 2026 | LONGNECKER, RICHARD M | reporter.nih.gov |
| Molecular dissecting and targeting YAP1 mediated cancer stemness and immune suppression in advanced gastric adenocarcinoma | NIH | National Cancer Institute | 2022 | $421,346 | September 1, 2022 | August 31, 2023 | SONG, SHUMEI | reporter.nih.gov |
| Contribution of Helicobacter pylori HomA and HomB to colonization and disease | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $419,365 | June 21, 2021 | May 31, 2025 | MELTON-CELSA, ANGELA | reporter.nih.gov |
| Advanced Development of Patient Ascites Therapeutic Response Biosensors | NIH | National Cancer Institute | 2025 | $419,133 | March 1, 2025 | February 29, 2028 | BOEHM, JESSE SAMUEL | reporter.nih.gov |
| Defining the phenotype and cancer penetrance of CTNNA1 loss-of-function germline variants | NIH | National Cancer Institute | 2023 to 2024 | $416,922 | December 15, 2022 | November 30, 2024 | KATONA, BRYSON WILLIAM | reporter.nih.gov |
| MDSC Polarization and Helicobacter-induced Gastric Metaplasia | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 | $409,682 | September 15, 2018 | August 31, 2024 | MERCHANT, JUANITA L. | reporter.nih.gov |
| Towards Interpretable Imaging-based Gastric Cancer Prognosis via Prototypical and Attentional Deep Learning | NIH | National Cancer Institute | 2025 | $402,728 | July 16, 2025 | June 30, 2027 | JIANG, YUMING | reporter.nih.gov |
| Efficacy of an Electrophile Scavenger in the Prevention of Gastrointestinal Inflammatory Carcinogenesis | NIH | National Cancer Institute | 2021 | $400,000 | April 9, 2021 | September 30, 2023 | RATHMACHER, JOHN A | reporter.nih.gov |
| S1PR1-targeted PET imaging to predict and monitor response to HER2-targeting antibody-drug conjugates | NIH | National Cancer Institute | 2024 | $399,829 | July 16, 2024 | June 30, 2026 | RIBEIRO PEREIRA, PATRICIA MANUELA | reporter.nih.gov |
| Mitigating Physical Function Decline in Older Adults with Gastroesophageal Cancer | NIH | National Institute on Aging | 2025 | $393,750 | September 22, 2025 | August 31, 2027 | JI, JINGRAN | reporter.nih.gov |
| Biodegradable nanocarriers and antibodies as targeting delivery vehicles for cancer metallodrugs | NIH | National Institute of General Medical Sciences | 2021 | $392,500 | June 1, 2018 | July 31, 2023 | CONTEL, MARIA | reporter.nih.gov |
| Assessing Helicobacter pylori and Diet to Develop Cancer Interventions in American Indian Communities in the Southwest | NIH | National Cancer Institute | 2022 to 2025 | $383,310 | September 4, 2020 | August 31, 2026 | PETE, DORNELL | reporter.nih.gov |
| Investigating gastric inflammation and preneoplastic progression driven by Helicobacter pylori infection | NIH | National Cancer Institute | 2024 to 2025 | $371,717 | July 7, 2022 | December 31, 2026 | O'BRIEN, VALERIE PHOEBE | reporter.nih.gov |
| Therapeutic potential of antitumorigenic soluble MET variants induced by splicing interference | NIH | National Cancer Institute | 2021 to 2022 | $352,565 | December 8, 2017 | November 30, 2022 | CARTEGNI, LUCA | reporter.nih.gov |
| Therapeutic potential of antitumorigenic soluble MET variants induced by splicing interference | NIH | National Cancer Institute | 2023 | $352,564 | December 8, 2017 | November 30, 2024 | CARTEGNI, LUCA | reporter.nih.gov |
| Functional characterization of novel oncogenic loci driving progression and immune response in gastrointestinal cancer | NIH | National Cancer Institute | 2021 to 2022 | $343,440 | September 1, 2021 | February 28, 2023 | LO, YUAN-HUNG | reporter.nih.gov |
| MDSC Polarization and Helicobacter-Induced Gastric Metaplasia | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 | $340,902 | September 15, 2018 | May 31, 2022 | MERCHANT, JUANITA L. | reporter.nih.gov |
| Investigating gastric inflammation and preneoplastic progression driven by Helicobacter pylori infection | NIH | National Cancer Institute | 2022 to 2023 | $335,664 | July 7, 2022 | July 31, 2023 | O'BRIEN, VALERIE PHOEBE | reporter.nih.gov |
| Prospective metabolomics investigation of gastric cancer risk in African Americans and European Whites with a low socioeconomic status | NIH | National Cancer Institute | 2023 | $300,000 | September 22, 2023 | August 31, 2024 | SHU, XIANG | reporter.nih.gov |
| Sox4 Dependent Parietal Cell Plasticity in Gastric Ulcer | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $251,250 | September 6, 2024 | July 31, 2026 | HUH, WON JAE | reporter.nih.gov |
| Regulation of the double-stranded RNA (dsRNA) response in gastric metaplasia and dysplasia | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2023 | $234,623 | August 1, 2022 | July 31, 2024 | SAENZ, JOSE BERNARDO | reporter.nih.gov |
| Causal determinants of drug resistance and metastasis in cancer with multimodal single cell data | NIH | National Cancer Institute | 2023 to 2024 | $231,852 | February 1, 2023 | January 31, 2026 | SALEHI, SOHRAB | reporter.nih.gov |
| Targeting of E-cadherin-negative diffuse-type gastric cancer | NIH | National Cancer Institute | 2025 | $163,500 | July 2, 2025 | June 30, 2027 | PARK, JAE-IL | reporter.nih.gov |
| Defining Inflammatory Triggers that Induce Diverse Subtypes of Gastric Metaplasia | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $161,206 | January 1, 2023 | December 31, 2026 | HOFT, STELLA GARDEN | reporter.nih.gov |
| Steering the next generation of NCI-sponsored clinical trials in gastroesophageal cancers | NIH | National Cancer Institute | 2024 to 2025 | $157,902 | September 19, 2024 | August 31, 2029 | KLEMPNER, SAMUEL J | reporter.nih.gov |
| Mechanisms of CDH1-inactivated advanced gastric adenocarcinoma tumorigenesis | NIH | National Cancer Institute | 2025 | $125,783 | February 1, 2025 | January 31, 2027 | ZOU, GENGYI | reporter.nih.gov |
| Redox Regulation of Host Ribosomal Proteins during Helicobacter pylori infection | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $97,477 | September 1, 2024 | December 31, 2026 | RAMANATHAN, RENUKA GANESH | reporter.nih.gov |
| Polyamine Dysregulation in the Gastric Epithelium during Helicobacter pylori Infection and its Impact on Gastric Carcinogenesis | NIH | National Cancer Institute | 2023 to 2025 | $71,917 | May 1, 2023 | May 12, 2025 | MCNAMARA, KARA | reporter.nih.gov |
| Role of the candidate protein methyltransferase METTL18 in cancer biology | NIH | National Cancer Institute | 2022 to 2023 | $69,618 | February 10, 2022 | September 30, 2023 | FRANCIS, JOEL | reporter.nih.gov |
| The role of VacA in Helicobacter pylori-host cell cholesterol homeostasis | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $49,538 | July 1, 2025 | June 30, 2028 | CASO, GEORGIA C | reporter.nih.gov |
| Investigating the roles and dynamics of the endoplasmic reticulum during paligenosis and metaplasia formation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 | $48,974 | August 27, 2024 | April 25, 2025 | NGUYEN, THANH | reporter.nih.gov |
| The Role of Epstein-Barr Virus-Induced Gene 3 (EBI3) in Preventing Gastric Atrophy and Metaplasia | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 | $46,730 | September 1, 2018 | June 30, 2022 | BOCKERSTETT, KEVIN A | reporter.nih.gov |
| Cell adhesion and ferroptosis: investigating a potential vulnerability in cancer cells | NIH | National Cancer Institute | 2021 | $46,036 | July 7, 2020 | July 6, 2022 | MINIKES, ALEXANDER MICHAEL | reporter.nih.gov |
| Assessing Helicobacter pylori and Diet to Develop Cancer Interventions in American Indian Communities in the Southwest | NIH | National Cancer Institute | 2021 | $46,003 | September 4, 2020 | August 31, 2022 | PETE, DORNELL | reporter.nih.gov |
| SOX9 as a key transcriptional regulator of SPEM cells in gastric carcinogenesis | NIH | National Cancer Institute | 2024 to 2025 | $41,738 | April 1, 2024 | May 31, 2025 | GUENTHER, ALEXIS A | reporter.nih.gov |
| The role of endothelial cells in the formation of early metastatic niches in the lung | NIH | National Cancer Institute | 2021 | $16,916 | September 17, 2021 | December 31, 2021 | RYEOM, SANDRA | reporter.nih.gov |
Organizations
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 63 | $39,849,889 | 0 | $0 |
| 2024 | 67 | $33,558,318 | 0 | $0 |
| 2023 | 62 | $31,916,685 | 0 | $0 |
| 2022 | 57 | $28,043,683 | 0 | $0 |
| 2021 | 46 | $19,917,420 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
| Open opportunity | Number | Agency | Listing | Closes | Award ceiling | Why it matches |
|---|---|---|---|---|---|---|
| Change of Recipient Organization (Type 7 Parent Clinical Trial Optional) | PA-24-254 | NIH | July 12, 2027 | Not listed | Notice number printed on 1 award here | |
| NCI Research Specialist (Clinician Scientist) Award (R50 Clinical Trial Not Allowed) | PAR-27-089 | NIH | 93.396 | November 2, 2026 | Not listed | Same assistance listing 93.396 as 28 awards here |
| NCI Research Specialist Award for Core and Laboratory-based Scientists (R50 Clinical Trial Not Allowed) | PAR-27-088 | NIH | 93.396 | November 20, 2026 | Not listed | Same assistance listing 93.396 as 28 awards here |
| NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed) | RFA-OD-24-011 | NIH | 93.396 | December 4, 2026 | Not listed | Same assistance listing 93.396 as 28 awards here |
| Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required) | PAR-24-214 | NIH | 93.396 | January 7, 2027 | $375,000 | Same assistance listing 93.396 as 28 awards here |
| Population Approaches to Reducing Alcohol-related Cancer Risk (R01 Clinical Trial Optional) | PAR-25-221 | NIH | 93.396 | January 7, 2027 | Not listed | Same assistance listing 93.396 as 28 awards here |
| Single Source: Coordinating Center (CC) for the Small Cell Lung Cancer (SCLC) Consortium (U24 Clinical Trial Not Allowed) | PAR-27-009 | NIH | 93.396 | January 25, 2027 | Not listed | Same assistance listing 93.396 as 28 awards here |
| Carcinogen Hazard Assessment Monographs Program (CHAMP) (R01 Clinical Trial Not Allowed) | RFA-CA-28-013 | NIH | 93.396 | February 9, 2027 | $700,000 | Same assistance listing 93.396 as 28 awards here |
| New Approaches for Measuring Brain Changes Across Longer Timespans (R21 Clinical Trial Optional) | PAR-25-272 | NIH | 93.396 | May 7, 2027 | Not listed | Same assistance listing 93.396 as 28 awards here |
| New Approaches for Measuring Brain Changes Across Longer Timespans (R01 Clinical Trial Optional) | PAR-25-279 | NIH | 93.396 | May 7, 2027 | Not listed | Same assistance listing 93.396 as 28 awards here |
| Advanced Development and Sustainment of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional) | RFA-CA-28-003 | NIH | 93.396 | June 11, 2027 | $600,000 | Same assistance listing 93.396 as 28 awards here |
| Successor-in-Interest (Type 6 Parent Clinical Trial Optional) | PA-24-253 | NIH | 93.396 | July 17, 2027 | Not listed | Same assistance listing 93.396 as 28 awards here |
| NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed) | PA-25-080 | NIH | 93.396 | September 7, 2027 | Not listed | Same assistance listing 93.396 as 28 awards here |
| Investigator-Focused Award (Parent R35) | PAR-28-037 | NIH | 93.396 | October 4, 2027 | Not listed | Same assistance listing 93.396 as 28 awards here |
| Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional) | RFA-CA-27-019 | NIH | 93.396 | October 19, 2027 | $300,000 | Same assistance listing 93.396 as 28 awards here |
| NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed) | PA-25-301 | NIH | 93.396 | January 7, 2028 | Not listed | Same assistance listing 93.396 as 28 awards here |
| NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Not Allowed) | PA-25-304 | NIH | 93.396 | January 7, 2028 | Not listed | Same assistance listing 93.396 as 28 awards here |
| NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Required) | PA-25-306 | NIH | 93.396 | January 7, 2028 | Not listed | Same assistance listing 93.396 as 28 awards here |
| Molecular Imaging of Inflammation in Cancer (R01 Clinical Trial Not Allowed) | PAR-24-311 | NIH | 93.396 | January 7, 2028 | $500,000 | Same assistance listing 93.396 as 28 awards here |
| Mechanisms that Impact Cancer Risk after Bariatric Surgery (R01 Clinical Trial Optional) | PAR-25-043 | NIH | 93.396 | January 7, 2028 | $500,000 | Same assistance listing 93.396 as 28 awards here |
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.